Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73151 - 73175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	SYNDIG1	79953	downregulated	Silicon Dioxide analog results in decreased expression of SYNDIG1 mRNA	20p11.21	A24195
Silicon dioxide	Approved	SYNE1	23345	upregulated	Silicon Dioxide analog results in increased expression of SYNE1 mRNA	6q25.2	A24195
Silicon dioxide	Approved	SYNE3	161176	downregulated	Silicon Dioxide results in decreased expression of SYNE3 mRNA	14q32.13	A24196
Silicon dioxide	Approved	SYNGR1	9145	downregulated	Silicon Dioxide analog results in decreased expression of SYNGR1 mRNA	22q13.1	A24195
Silicon dioxide	Approved	SYNGR4	23546	downregulated	Silicon Dioxide analog results in decreased expression of SYNGR4 mRNA	19q13.33	A24195
Silicon dioxide	Approved	SYNM	23336	upregulated	Silicon Dioxide analog results in increased expression of SYNM mRNA	15q26.3	A24195
Silicon dioxide	Approved	SYNPO2	171024	downregulated	Silicon Dioxide analog results in decreased expression of SYNPO2 mRNA	4q26	A24194
Silicon dioxide	Approved	SYNRG	11276	upregulated	Silicon Dioxide results in increased expression of SYNRG mRNA	17q12	A24196
Silicon dioxide	Approved	SYT1	6857	downregulated	Silicon Dioxide analog results in decreased expression of SYT1 mRNA	12q21.2	A24195
Silicon dioxide	Approved	SYT1	6857	upregulated	Silicon Dioxide analog results in increased expression of SYT1 mRNA	12q21.2	A24194
Silicon dioxide	Approved	SYT11	23208	downregulated	Silicon Dioxide analog results in decreased expression of SYT11 mRNA	1q22	A24195
Silicon dioxide	Approved	SYT13	57586	downregulated	Silicon Dioxide analog results in decreased expression of SYT13 mRNA	11p11.2	A24195
Silicon dioxide	Approved	SYT14	255928	upregulated	Silicon Dioxide analog results in increased expression of SYT14 mRNA	1q32.2	A24195
Silicon dioxide	Approved	SYT17	51760	downregulated	Silicon Dioxide analog results in decreased expression of SYT17 mRNA	16p12.3	A24195
Silicon dioxide	Approved	SYT3	84258	downregulated	Silicon Dioxide analog results in decreased expression of SYT3 mRNA	19q13.33	A24195
Silicon dioxide	Approved	SYTL3	94120	upregulated	Silicon Dioxide analog results in increased expression of SYTL3 mRNA	6q25.3	A24195
Silicon dioxide	Approved	SYTL4	94121	downregulated	Silicon Dioxide analog results in decreased expression of SYTL4 mRNA	Xq22.1	A24195
Silicon dioxide	Approved	TAC1	6863	upregulated	Silicon Dioxide analog results in increased expression of TAC1 mRNA	7q21.3	A24194
Silicon dioxide	Approved	TAC3	6866	downregulated	Silicon Dioxide analog results in decreased expression of TAC3 mRNA	12q13.3	A24195
Silicon dioxide	Approved	TACSTD2	4070	upregulated	Silicon Dioxide results in increased expression of TACSTD2 mRNA	1p32.1	A24196
Silicon dioxide	Approved	TADA2A	6871	downregulated	Silicon Dioxide results in decreased expression of TADA2A mRNA	17q12	A24196
Silicon dioxide	Approved	TAF1B	9014	upregulated	Silicon Dioxide analog results in increased expression of TAF1B mRNA	2p25.1	A24195
Silicon dioxide	Approved	TAF3	83860	downregulated	Silicon Dioxide analog results in decreased expression of TAF3 mRNA	10p14	A24195
Silicon dioxide	Approved	TAF5	6877	upregulated	Silicon Dioxide results in increased expression of TAF5 mRNA	10q24.33	A24196
Silicon dioxide	Approved	TAF5L	27097	upregulated	Silicon Dioxide analog results in increased expression of TAF5L mRNA	1q42.13	A24194

Displaying entries 73151 - 73175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability